Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707) Total Stockholders Equity : ¥6,577 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Nanjing King-Friend Biochemical Pharmaceutical Co Total Stockholders Equity?

Nanjing King-Friend Biochemical Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥6,577 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Nanjing King-Friend Biochemical Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2025 was ¥4.07. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Nanjing King-Friend Biochemical Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.23.

Nanjing King-Friend Biochemical Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Nanjing King-Friend Biochemical Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing King-Friend Biochemical Pharmaceutical Co Total Stockholders Equity Chart

Nanjing King-Friend Biochemical Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

3,722.44

5,377.92

6,170.64

5,801.97

6,491.67

Nanjing King-Friend Biochemical Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															5,982.03	6,070.04	6,270.41	6,491.67	6,576.89

Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Nanjing King-Friend Biochemical Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(6576.885	-	0)	/	1615.635
	=	4.07

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Nanjing King-Friend Biochemical Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(651.126	+	848.498)	/	6576.885
	=	0.23

Nanjing King-Friend Biochemical Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Nanjing King-Friend Biochemical Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing King-Friend Biochemical Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

1/16 Xuefu Road, Nanjing High-Tech Zone, Nanjing, CHN, 210061

Website

http://www.nkf-pharma.com

Nanjing King-Friend Biochemical Pharmaceutical Co Ltd is a China-based company engaged in the research and development, import and export of medicines and health products. The main products of the company are Heparin sodium and low molecular weight heparin. Geographically, the business activities are carried out through China and it exports the product mainly to the European and American countries.

Executives

Huang Xi Wei	Director
Liu Zu Qing	Supervisors
Xie Ju Hua	Director
Wu Gui Ping	senior management
Tang Yong Qun	Director
Qian Xiao Jie	senior management

Nanjing King-Friend Biochemical Pharmaceutical Co Headlines

No Headlines